• India
  • +91 98480 35983
  • India
  • USA
  • +1-408-508-5432
  • USA
  • Australia
  • +61-405-871-726
  • Australia
  • or
  • D-U-N-S : 854321383
  • LEI : 9845004484A1C4C82E71
  • MSME : UDYAM-TS-02-0059615

Rushi Pharma provides structured procurement services for Reference Listed Drugs (RLDs) to support pharmaceutical companies involved in ANDA submissions, bioequivalence (BE) studies, and regulatory filings.

We understand the critical role RLDs play in generic drug development and ensure sourcing is handled with accuracy, traceability, and regulatory awareness.

Our RLD Sourcing Services Include:

  • Identification of correct RLD as per USFDA Orange Book
  • Procurement from authorized distribution channels
  • Verification of batch details and labelling
  • Controlled storage and handling
  • Shipment coordination with documentation support
  • Batch traceability and supply confirmation

Why Accurate RLD Sourcing Matters:

RLD integrity directly impacts:

  • Bioequivalence study outcomes
  • Regulatory submission accuracy
  • ANDA filing timelines
  • Product development alignment

We ensure authenticity and supply chain transparency to minimize regulatory risk.

  • D-U-N-S: 854321383
  • LEI: 9845004484A1C4C82E71
  • MSME UDYAM-TS-02-0059615
Scroll To Top